Optimizing Pregnancy and Treatment Interventions for Moms 2.0

优化妈妈怀孕和治疗干预 2.0

基本信息

  • 批准号:
    9789115
  • 负责人:
  • 金额:
    $ 68.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-30 至 2021-09-29
  • 项目状态:
    已结题

项目摘要

PUBLIC ABSTRACT Opioid use disorder (OUD) among pregnant women results in a number of adverse consequences in infants and mothers, including: preterm birth, low birth weight, birth defects, neonatal abstinence syndrome (NAS), and cog- nitive deficits in children. Pregnant women with OUD have elevated rates of HIV/HCV infection, psychiatric dis- orders, non-opioid substance use disorder (SUD); and social, financial, and employment problems. Pregnant women with OUD also have had sharp increases in treatment admissions in the last decade. Unfortunately, pregnant women with OUD also have high rates of treatment dropout. While medication assisted treatment com- bined with psychosocial services is the standard of care for opioid dependent pregnant women, it is not clear which psychosocial service is optimal. One promising intervention is patient navigation (PN), an evidence-based practice shown to be effective for a variety of psycho/social/emotional outcomes. PN has been shown to benefit problems common in those with OUD, including access to treatment, engagement in care, and motivation to improve health behaviors. The current study will build on our preliminary studies and further establish the internal and external validity of these findings and the potential value of the PN intervention. The first Specific Aim of this project will involve using Marlatt and Gordon’s relapse prevention model wherein we will infuse relapse preven- tion content for identification/prevention of (1) high risk situations of discontinuance of medication assisted treat- ment and (2) initial abstinence lapses. The second Specific Aim of this project will involve expanding our proof- of-concept study intervention and protocols to facilitate a multisite, randomized, system-wide trial; which will include uniform intervention, recruitment, randomization, study staff blinding, formalized follow up procedures, and staff training materials. The third Specific Aim of this project will involve implementing and testing the ex- panded intervention and protocols with pregnant women with OUD (n=122) at two hospital sites, Magee-Wom- ens Hospital of UPMC and the University of Utah Hospital. Participants will be randomized to PN or standard care and will be assessed at baseline, prior to delivery, and 2 and 6 months postnatal. Completion of this project will result in necessary protocols/procedures and pilot data preparatory to a large scale, fully powered, multisite randomized trial. This work addresses a major public health issue, opioid dependence during pregnancy, and further establishes an evidence base for protecting health of mother and baby.
公共抽象

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gerald T. Cochran其他文献

Prescribing, Prescription Monitoring, and Health Policy
处方、处方监测和健康政策
  • DOI:
    10.1007/978-3-030-16257-3_11
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Gordon;Gerald T. Cochran;M. Smid;A. Manhapra;S. Kertesz
  • 通讯作者:
    S. Kertesz
Caring for Opioid Dependent Pregnant Women: Prenatal and Postpartum Care Considerations
照顾阿片类药物依赖孕妇:产前和产后护理注意事项
  • DOI:
    10.1097/01.aoa.0000515760.42651.7a
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    E. Krans;Gerald T. Cochran;D. Bogen
  • 通讯作者:
    D. Bogen
Analysis of the Uniform Accident and Sickness Policy Provision Law: Lessons for Social Work Practice, Policy, and Research
统一事故和疾病政策规定法分析:社会工作实践、政策和研究的经验教训
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Gerald T. Cochran
  • 通讯作者:
    Gerald T. Cochran
Abuse-Deterrent Opioid Formulations and the Opioid Crisis: A Pharmacist's Perspective.
防滥用阿片类药物制剂和阿片类药物危机:药剂师的视角。
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Shannon Gadd;Nicholas Cox;J. Samuelson;Amy Kenney;Kyle M. Turner;Gerald T. Cochran
  • 通讯作者:
    Gerald T. Cochran
Latent classes and transitions for brief alcohol interventions in trauma settings : clinical and policy implications
创伤环境中短暂酒精干预的潜在类别和转变:临床和政策影响
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Gerald T. Cochran
  • 通讯作者:
    Gerald T. Cochran

Gerald T. Cochran的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gerald T. Cochran', 18)}}的其他基金

Co-Use of Opioid Medications and Alcohol Prevention Study (COAPS)
阿片类药物与酒精预防研究 (COAPS) 的共同使用
  • 批准号:
    10629264
  • 财政年份:
    2022
  • 资助金额:
    $ 68.83万
  • 项目类别:
Adaptation and Implementation of a Community Pharmacy-Based Prescription Drug Monitoring Pro-gram Opioid Risk Assessment Tool
基于社区药房的处方药监测计划阿片类药物风险评估工具的调整和实施
  • 批准号:
    10621513
  • 财政年份:
    2022
  • 资助金额:
    $ 68.83万
  • 项目类别:
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial
处方阿片类药物滥用:药剂师主导的服务点干预疗效试验
  • 批准号:
    10204570
  • 财政年份:
    2021
  • 资助金额:
    $ 68.83万
  • 项目类别:
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial
处方阿片类药物滥用:药剂师主导的服务点干预疗效试验
  • 批准号:
    10551886
  • 财政年份:
    2021
  • 资助金额:
    $ 68.83万
  • 项目类别:
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial
处方阿片类药物滥用:药剂师主导的服务点干预疗效试验
  • 批准号:
    10371130
  • 财政年份:
    2021
  • 资助金额:
    $ 68.83万
  • 项目类别:
Greater Intermountain Node
大山间节点
  • 批准号:
    10583147
  • 财政年份:
    2019
  • 资助金额:
    $ 68.83万
  • 项目类别:
Greater Intermountain Node
大山间节点
  • 批准号:
    10371229
  • 财政年份:
    2019
  • 资助金额:
    $ 68.83万
  • 项目类别:
Greater Intermountain Node
大山间节点
  • 批准号:
    10581531
  • 财政年份:
    2019
  • 资助金额:
    $ 68.83万
  • 项目类别:
Prescription opioid misuse: Pharmacist-delivered intervention at point of service
处方阿片类药物滥用:药剂师在服务点提供干预
  • 批准号:
    9297643
  • 财政年份:
    2017
  • 资助金额:
    $ 68.83万
  • 项目类别:
The Influence of Formulary Management Strategies on Opioid Medication Use.
处方管理策略对阿片类药物使用的影响。
  • 批准号:
    8821933
  • 财政年份:
    2014
  • 资助金额:
    $ 68.83万
  • 项目类别:

相似海外基金

Studies on the Treatment of Opioid Use Disorder in Pregnancy
妊娠期阿片类药物使用障碍的治疗研究
  • 批准号:
    489082
  • 财政年份:
    2023
  • 资助金额:
    $ 68.83万
  • 项目类别:
    Operating Grants
Establishment of predictive factor of oncologic / pregnancy outcome on fertility sparing treatment for young patients with endometrial cancer
年轻子宫内膜癌患者保留生育治疗的肿瘤/妊娠结局预测因素的建立
  • 批准号:
    23K08808
  • 财政年份:
    2023
  • 资助金额:
    $ 68.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Redefining the diagnosis and treatment of hypertension in pregnancy through the integration of placental growth factor (PlGF) testing.
通过整合胎盘生长因子(PlGF)检测重新定义妊娠期高血压的诊断和治疗。
  • 批准号:
    486949
  • 财政年份:
    2023
  • 资助金额:
    $ 68.83万
  • 项目类别:
    Operating Grants
Expanding Access to Pregnancy Specific Opioid Use Disorder Treatment in Jail: Piloting and Adaptable Implementation Strategy to Advance Equitable and Patient-Centered Care
扩大监狱中妊娠期特定阿片类药物使用障碍治疗的机会:试点和适应性实施策略,以促进公平和以患者为中心的护理
  • 批准号:
    10593393
  • 财政年份:
    2023
  • 资助金额:
    $ 68.83万
  • 项目类别:
Brain exosome biomarker targets to optimize pharmacologic treatment of depression in pregnancy
脑外泌体生物标志物靶向优化妊娠期抑郁症的药物治疗
  • 批准号:
    10673014
  • 财政年份:
    2022
  • 资助金额:
    $ 68.83万
  • 项目类别:
Brain exosome biomarker targets to optimize pharmacologic treatment of depression in pregnancy
脑外泌体生物标志物靶向优化妊娠期抑郁症的药物治疗
  • 批准号:
    10543638
  • 财政年份:
    2022
  • 资助金额:
    $ 68.83万
  • 项目类别:
A Non-Inferiority Trial Testing Delivery of Written Exposure Therapy by Community Health Workers for Treatment of PTSD During Pregnancy
社区卫生工作者书面暴露疗法治疗妊娠期 PTSD 的非劣效性试验
  • 批准号:
    10685463
  • 财政年份:
    2022
  • 资助金额:
    $ 68.83万
  • 项目类别:
Intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine plus dihydroartemisinin-piperaquine to reduce adverse pregnancy outcomes and prevent malaria in Papua New Guinea: a randomised controlled trial
在巴布亚新几内亚,用磺胺多辛-乙胺嘧啶加双氢青蒿素-哌喹对妊娠期进行间歇性预防治疗,以减少不良妊娠结局并预防疟疾:一项随机对照试验
  • 批准号:
    nhmrc : 2000780
  • 财政年份:
    2022
  • 资助金额:
    $ 68.83万
  • 项目类别:
    Clinical Trials and Cohort Studies Grants
Understanding Barriers and Facilitators to the Treatment of Sleep-Disordered Breathing in Pregnancy and Postpartum
了解治疗妊娠期和产后睡眠呼吸障碍的障碍和促进因素
  • 批准号:
    468545
  • 财政年份:
    2022
  • 资助金额:
    $ 68.83万
  • 项目类别:
    Operating Grants
Novel therapeutic strategies for the treatment of recurrent pregnancy loss by elucidating the function of endometrium and decidua with a focus on insulin response
通过阐明子宫内膜和蜕膜的功能(重点关注胰岛素反应)来治疗复发性流产的新治疗策略
  • 批准号:
    22K09575
  • 财政年份:
    2022
  • 资助金额:
    $ 68.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了